Skip to main content
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
. 1975 Jul;9(2):70–73. doi: 10.1136/bjsm.9.2.70

Effects of large doses of anabolic steroids.

R A Harkness, B H Kilshaw, B M Hobson
PMCID: PMC1859224  PMID: 1182412

Full text

PDF
70

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adhikary P. M., Harkness R. A. Production of the parent hydrocarbons from steroid drugs and their separation by gas chromatography. J Chromatogr. 1969 Jun 3;42(1):29–38. doi: 10.1016/s0021-9673(01)80584-7. [DOI] [PubMed] [Google Scholar]
  2. Adhikary P. M., Harkness R. A. The use of carbon skeleton chromatography for the detection of steroid drug metabolites: the metabolism of anabolic steroids in man. Acta Endocrinol (Copenh) 1971;67(4):721–732. doi: 10.1530/acta.0.0670721. [DOI] [PubMed] [Google Scholar]
  3. Allen D. M., Fine M. H., Necheles T. F., Dameshek W. Oxymetholone therapy in aplastic anemia. Blood. 1968 Jul;32(1):83–89. [PubMed] [Google Scholar]
  4. Boris A., Stevenson R. H., Trmal T. Comparative androgenic, myotrophic and antigonadotrophic properties of some anabolic steroids. Steroids. 1970 Jan;15(1):61–71. doi: 10.1016/s0039-128x(70)80004-6. [DOI] [PubMed] [Google Scholar]
  5. DESAULLES P. A., KRAEHENBUEHL C., SCHULER W., BEIN H. J. [Experimental study of dianabol, a new anabolic agent. 17 alpha-Methyl-17 beta-hydroxy-androstane-1,4-diene-3-one]. Schweiz Med Wochenschr. 1959 Dec 12;89:1313–1318. [PubMed] [Google Scholar]
  6. FERRARI R. A., ARNOLD A. INHIBITION OF BETA-HYDROXYSTEROID DEHYDROGENASE. I. STRUCTURAL CHARACTERISTICS OF SOME STEROIDAL INHIBITORS. Biochim Biophys Acta. 1963 Nov 8;77:349–356. doi: 10.1016/0006-3002(63)90510-9. [DOI] [PubMed] [Google Scholar]
  7. FERRARI R., ARNOLD A. INHIBITION OF BETA-HYDROXYSTEROID DEHYDROGENASE. II. KINETICS AND PH EFFECT. Biochim Biophys Acta. 1963 Nov 8;77:357–364. doi: 10.1016/0006-3002(63)90511-0. [DOI] [PubMed] [Google Scholar]
  8. HAYES K. J. THE SO-CALLED 'LEVATOR ANI' OF THE RAT. Acta Endocrinol (Copenh) 1965 Mar;48:337–347. doi: 10.1530/acta.0.0480337. [DOI] [PubMed] [Google Scholar]
  9. Hvidberg E. F., Dayton P. G., Read J. M., 3rd, Wilson C. H. Studies of the interaction of phenylbutazone, oxyphenbutazone and methandrostenolone in man. Proc Soc Exp Biol Med. 1968 Nov;129(2):438–443. doi: 10.3181/00379727-129-33338. [DOI] [PubMed] [Google Scholar]
  10. KINCL F. A., MAQUEO M., DORFMAN R. I. INFLUENCE OF VARIOUS STEROIDS ON TESTES AND ACCESSORY SEX ORGANS IN THE RAT. Acta Endocrinol (Copenh) 1965 May;49:145–154. doi: 10.1530/acta.0.0490145. [DOI] [PubMed] [Google Scholar]
  11. Klaiber E. L., Henzl M. R., Lloyd C. W., Segre E. J. Corpus luteum-inhibiting action of oxymetholone. J Clin Endocrinol Metab. 1973 Jan;36(1):142–147. doi: 10.1210/jcem-36-1-142. [DOI] [PubMed] [Google Scholar]
  12. LIDDLE G. W., BURKE H. A., Jr Anabolic steroids in clinical medicine. Helv Med Acta. 1960 Dec;27:504–513. [PubMed] [Google Scholar]
  13. Lennon H. D. Relative effects of 17-alpha-alkylated anabolic steroids on sulfobromophthalein (BSP) retention in rabbits. J Pharmacol Exp Ther. 1966 Jan;151(1):143–150. [PubMed] [Google Scholar]
  14. MACLEOD J. Semen quality in 1000 men of known fertility and in 800 cases of infertile marriage. Fertil Steril. 1951 Mar-Apr;2(2):115–139. doi: 10.1016/s0015-0282(16)30482-4. [DOI] [PubMed] [Google Scholar]
  15. Wade N. Anabolic Steroids: Doctors Denounce Them, but Athletes Aren't Listening. Science. 1972 Jun 30;176(4042):1399–1403. doi: 10.1126/science.176.4042.1399. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES